BPC-157 vs TB-500
The two most popular healing peptides, head to head. BPC-157 excels at local tissue repair (especially gut and tendons). TB-500 works systemically throughout your body. Most people stack both — here's why and how.
BPC-157 (from gastric juice) drives local angiogenesis and tissue repair — especially strong for gut, tendons, and ligaments. TB-500 (thymosin beta-4 fragment) works systemically with anti-fibrotic and anti-inflammatory properties. Neither has published human RCTs, but both have extensive animal data and widespread anecdotal use. The combination is the most popular healing peptide stack.
Best for: People recovering from tendon, ligament, or muscle injuries. Those with gut issues (BPC-157 specifically). Anyone dealing with chronic, fibrotic injuries (TB-500 specifically). Athletes seeking accelerated recovery.
Dive deeper into the researchKey considerations
- Injection site reactions (both peptides)
- Mild nausea at higher BPC-157 doses
- TB-500: temporary flu-like symptoms reported by some users
Side-by-side comparison
| Parameter | BPC-157 | TB-500 |
|---|---|---|
| Origin | Gastric juice pentadecapeptide | Thymosin Beta-4 fragment |
| Mechanism | Angiogenesis (VEGF), GH receptor, nitric oxide | Actin sequestration, cell migration, anti-fibrotic |
| Healing focus | Local — gut, tendons, ligaments, muscles | Systemic — works throughout the body |
| Gut healing | Excellent — ulcers, IBD, leaky gut | Minimal gut-specific data |
| Anti-fibrotic | Moderate | Strong — key differentiator for chronic injuries |
| Administration | SC (near injury) or oral (gut) | SC (any site — systemic) |
| Typical dose | 250–500 mcg, 1–2x daily | 2–5 mg, 2x/week → weekly |
| Oral option | Yes — for gut healing | No |
| Human RCTs | None | None |
When to choose BPC-157
- Gut issues — ulcers, IBD, leaky gut, NSAID damage
- Localised tendon/ligament injuries — Achilles, rotator cuff, patellar tendinopathy
- Want an oral option — BPC-157 retains bioactivity when taken orally
- Neuroprotection — dopaminergic system support in animal models
When to choose TB-500
- Multiple injury sites — systemic distribution means one injection covers everything
- Chronic fibrotic injuries — old scar tissue, adhesions, fibrotic damage
- Cardiac recovery — animal data on cardiac tissue regeneration
- Hair growth — unexpected but reported benefit from thymosin beta-4
The BPC-157 + TB-500 stack
BPC-157: 250–500 mcg subcutaneous, 1–2x daily (inject near injury for musculoskeletal). TB-500: 2.5–5 mg subcutaneous (any site), 2x/week for 4 weeks (loading), then 2.5 mg weekly for 4 weeks (maintenance). Total cycle: 6–8 weeks.
The combination works because the mechanisms are complementary: BPC-157 drives local blood vessel formation and growth factor signaling, while TB-500 handles systemic inflammation reduction and anti-fibrotic tissue remodeling.
Tracking a peptide protocol?
eterni connects your labs, supplements, and retests — so you can see whether your protocol is actually working.
Get early accessFrequently Asked Questions
Should I use BPC-157 or TB-500 for tendon injuries?
Both show promise. BPC-157 excels at local tissue repair (especially tendons near the GI tract) while TB-500 has broader systemic anti-fibrotic effects. Many practitioners stack both — BPC-157 injected near the injury for targeted healing, TB-500 at any site for systemic support.
Can I take BPC-157 orally?
Yes. BPC-157 demonstrates oral bioactivity in animal studies for gut healing and even some systemic effects. For gut issues specifically, oral is the preferred route. For musculoskeletal injuries, subcutaneous injection near the injury likely delivers higher local concentrations. TB-500 is injection-only.
Is it safe to stack BPC-157 and TB-500?
The stack is one of the most common peptide combinations. No human RCTs exist, but extensive anecdotal and animal data suggest good tolerability. Typical protocol: 250–500 mcg BPC-157 + 2.5–5 mg TB-500, injected subcutaneously for 4–8 weeks.
Are these peptides legal in India?
Both occupy a grey area — not scheduled drugs but not approved as medicines either. Available from research peptide vendors and some compounding pharmacies. Quality verification (third-party HPLC testing) is essential.
Mechanism deep dive
BPC-157 works primarily through angiogenesis (VEGF upregulation), nitric oxide system modulation, and GH receptor interaction. It promotes new blood vessel formation at injury sites, accelerating nutrient and immune cell delivery for repair.
TB-500 works through actin sequestration — it binds G-actin to promote cell migration, which is essential for tissue remodeling. Its anti-fibrotic properties come from reducing excessive collagen deposition (scar tissue), and it has potent anti-inflammatory effects systemically.
Evidence summary
- BPC-157: 100+ animal studies covering gut ulcers, tendon healing, nerve regeneration, brain injury. No published human RCTs
- TB-500: 50+ animal studies on wound healing, cardiac repair, anti-fibrosis, and hair growth. No published human RCTs
- Combination: No studies on the combination specifically; rationale is mechanism-based (complementary pathways)
Side effects & considerations
- BPC-157: Generally well-tolerated; occasional nausea, injection site reactions. Some concern about potential angiogenesis in pre-existing tumors (theoretical)
- TB-500: Mild flu-like symptoms in some users, injection site reactions. Theoretical concern about promoting growth in existing cancers via cell migration
- Both: Quality varies enormously between vendors; always verify with third-party HPLC/COA testing
Who should avoid them: People with active cancer (angiogenesis and cell migration concerns), pregnant or breastfeeding women, and those on immunosuppressants.
Sourcing in India
- Research-grade vials — lyophilized powder from Indian and international peptide vendors; affordable but requires reconstitution
- Oral BPC-157 capsules — available from select longevity clinics and online vendors
- Compounding pharmacies — some prepare both peptides under physician prescription
- Quality testing — always request Certificate of Analysis with HPLC purity ≥98% and endotoxin levels
Know what's working. Know what's not.
eterni connects your lab results, supplements, and retests — so you can see the trajectory, not just a snapshot.
Join the waitlist